Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Head & Neck 3

Conditions

Breast Neoplasms 11Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Ovarian Epithelial 4Carcinoma, Intraductal, Noninfiltrating 4Breast Carcinoma In Situ 4Brain Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Ovarian Neoplasms 3Liver Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Salivary Gland Neoplasms 2Precancerous Conditions 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Gliosarcoma 2Glioblastoma 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1

Interventions

Cisplatin 141Radiotherapy 115Cetuximab 95Docetaxel 69Radiotherapy, Intensity-Modulated 55Carboplatin 47pembrolizumab 46Surveys and Questionnaires 46Paclitaxel 41Fluorouracil 39Radiation 29Blood Specimen Collection 27Drug Therapy 26Erlotinib Hydrochloride 23Nivolumab 21Surgical Procedures, Operative 17Standard of Care 16Magnetic Resonance Spectroscopy 16Radiosurgery 14Pemetrexed 14Gemcitabine 14Everolimus 13Celecoxib 13durvalumab 12Low-Level Light Therapy 12Immunohistochemistry 12Cyclophosphamide 12Capecitabine 12Amifostine 12Chemoradiotherapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Head and Neck Neoplasms × Mass Spectrometry × Clear all
NCT00601913 2018-07-05

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00899769 2017-03-14

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

Vanderbilt University Medical Center

Completed
100 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡